Abstract
First line anti-tubercular drugs are known to cause various adverse drug reactions including cutaneous reactions. We report a rare case of anti-tubercular treatment (ATT) induced lichenoid skin reaction in a 58 years old female with no prior history of rashes. She was put on fi xed dose combination (FDC) tablets of fi rst line anti-tuberculosis drugs and developed reaction one month after initiation of therapy.
Highlights
Lichenoid skin reactions are rare cutaneous manifestation to develop in the patients on antitubercular drug[1]
The spectrum of cutaneous adverse drug reaction associated with anti-tubercular treatment (ATT) include various syndromes like Stevens – Johnson syndrome, lichenoid skin reaction, DRESS syndrome, and drug hypersensitivity syndrome[2]
After a huge success in the outcomes, fixed dose combination (FDC) was introduced for all ATT drug regimen under Directly Observed Treatment Short-course (DOTS) in 2015
Summary
Lichenoid Skin Reaction in a Patient on Anti-Tubercular Drugs: a Rare Case Report. First line anti-tubercular drugs are known to cause various adverse drug reactions including cutaneous reactions. We report a rare case of anti-tubercular treatment (ATT) induced lichenoid skin reaction in a 58 years old female with no prior history of rashes. She was put on fixed dose combination (FDC) tablets of first line anti-tuberculosis drugs and developed reaction one month after initiation of therapy.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
